title: Treatment of acute myeloid leukemia with intermediate-dose cytosine arabinoside and mitoxantrone.
authors.forename: F
authors.initials: F
authors.lastname: Brito-Babapulle
authors.forename: D
authors.initials: D
authors.lastname: Catovsky
authors.forename: A C
authors.initials: AC
authors.lastname: Newland
authors.forename: J M
authors.initials: JM
authors.lastname: Goldman
authors.forename: D A
authors.initials: DA
authors.lastname: Galton
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage*; D013997:Time Factors
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone